Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pontocerebellar hypoplasia type 7 (PCH7) is a novel very rare form of pontocerebellar hypoplasia with unknown etiology and poor prognosis reported in four patients and is characterized clinically during the neonatal period by hypotonia, no palpable gonads, micropenis and from infancy by progressive microcephaly, apneic episodes, poor feeding, seizures and regression of penis. MRI demonstrates a pontocerebellar hypoplasia. PCH7 is expressed as PCH with 46,XY disorder of sex development in individuals with XY karyotype, and may be expressed as PCH only in individuals with XX karyotype.
Features include always present findings: Hypoplasia of the pons, Muscle weakness, Intellectual disability, and Skeletal muscle atrophy and others; and very common findings: Progressive microcephaly, Hypertonia, Ambiguous genitalia, and Overactive reflexes (hyperreflexia) and others. 49 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 15 | Seizure, Ataxia, Hydrocephalus |
TOE1 function has not been fully characterized.
Pontocerebellar hypoplasia type 7 is associated with mutations in the TOE1 gene on chromosome 1.
Genetic testing for TOE1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 always present features, 5 very common features, 11 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pontocerebellar hypoplasia type 7.
4 publications have been identified in PubMed for pontocerebellar hypoplasia type 7. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Pachapure SS (2026). [PMID: 41847829](https://pubmed.ncbi.nlm.nih.gov/41847829/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Yang A (2025). [PMID: 39524536](https://pubmed.ncbi.nlm.nih.gov/39524536/). *Genes Dis*. [Basic Science / Preclinical]
Zavala L (2025). [PMID: 41000718](https://pubmed.ncbi.nlm.nih.gov/41000718/). *bioRxiv*. [Basic Science / Preclinical]
Kuroda Y (2024). [PMID: 38605133](https://pubmed.ncbi.nlm.nih.gov/38605133/). *J Hum Genet*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 8:32 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles |
6 |
Low muscle tone (hypotonia), Muscle weakness, Skeletal muscle atrophy |
Eyes | 3 | Nystagmus, Damage to the optic nerve (optic atrophy), Oculomotor apraxia |
Head and neck | 3 | Progressive microcephaly, High palate, Thick upper lip vermilion |
Bones and joints | 2 | Skeletal muscle atrophy, Severe backward arching of the body (opisthotonus) |
Skin | 1 | Hypopigmentation of the skin |
Digestive system | 1 | Feeding difficulties |
Lungs and breathing | 1 | Apnea |
AI-curated news mentioning pontocerebellar hypoplasia type 7
Updated May 23, 2026
Research identifies mutations in the TOE1 gene that impair its thermal stability, ribonuclease activity, and oligomerization, contributing to pontocerebellar hypoplasia. This discovery enhances understanding of the molecular mechanisms underlying this rare disease.
A study published in PubMed reveals novel genetic variants associated with pontocerebellar hypoplasia in an Iranian cohort. This research enhances understanding of the genetic underpinnings of this rare neurological disorder.